TRIMAS CORP (TRS)

US8962152091 - Common Stock

26.17  +0.38 (+1.47%)

Fundamental Rating

4

TRS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 23 industry peers in the Containers & Packaging industry. TRS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. TRS has a valuation in line with the averages, but it does not seem to be growing.



3

1. Profitability

1.1 Basic Checks

TRS had positive earnings in the past year.
TRS had a positive operating cash flow in the past year.
TRS had positive earnings in 4 of the past 5 years.
TRS had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of 3.01%, TRS is in line with its industry, outperforming 43.48% of the companies in the same industry.
TRS's Return On Equity of 5.91% is on the low side compared to the rest of the industry. TRS is outperformed by 60.87% of its industry peers.
TRS's Return On Invested Capital of 4.58% is on the low side compared to the rest of the industry. TRS is outperformed by 65.22% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for TRS is below the industry average of 8.36%.
Industry RankSector Rank
ROA 3.01%
ROE 5.91%
ROIC 4.58%
ROA(3y)4.16%
ROA(5y)2.81%
ROE(3y)8.38%
ROE(5y)5.13%
ROIC(3y)5.49%
ROIC(5y)5.32%

1.3 Margins

The Profit Margin of TRS (4.51%) is comparable to the rest of the industry.
TRS's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 7.81%, TRS is doing worse than 65.22% of the companies in the same industry.
TRS's Operating Margin has declined in the last couple of years.
TRS has a better Gross Margin (22.76%) than 69.57% of its industry peers.
In the last couple of years the Gross Margin of TRS has declined.
Industry RankSector Rank
OM 7.81%
PM (TTM) 4.51%
GM 22.76%
OM growth 3Y8.08%
OM growth 5Y-12.76%
PM growth 3YN/A
PM growth 5Y-17.5%
GM growth 3Y-1.26%
GM growth 5Y-4.32%

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so TRS is destroying value.
The number of shares outstanding for TRS has been reduced compared to 1 year ago.
Compared to 5 years ago, TRS has less shares outstanding
TRS has a better debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 2.01 indicates that TRS is not a great score, but indicates only limited risk for bankruptcy at the moment.
TRS has a Altman-Z score of 2.01. This is comparable to the rest of the industry: TRS outperforms 56.52% of its industry peers.
The Debt to FCF ratio of TRS is 11.71, which is on the high side as it means it would take TRS, 11.71 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 11.71, TRS perfoms like the industry average, outperforming 47.83% of the companies in the same industry.
TRS has a Debt/Equity ratio of 0.58. This is a neutral value indicating TRS is somewhat dependend on debt financing.
The Debt to Equity ratio of TRS (0.58) is better than 86.96% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 11.71
Altman-Z 2.01
ROIC/WACC0.61
WACC7.5%

2.3 Liquidity

TRS has a Current Ratio of 2.49. This indicates that TRS is financially healthy and has no problem in meeting its short term obligations.
TRS has a Current ratio of 2.49. This is amongst the best in the industry. TRS outperforms 91.30% of its industry peers.
A Quick Ratio of 1.29 indicates that TRS should not have too much problems paying its short term obligations.
With an excellent Quick ratio value of 1.29, TRS belongs to the best of the industry, outperforming 86.96% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.49
Quick Ratio 1.29

3

3. Growth

3.1 Past

The earnings per share for TRS have decreased strongly by -17.92% in the last year.
The Earnings Per Share has been decreasing by -0.11% on average over the past years.
Looking at the last year, TRS shows a small growth in Revenue. The Revenue has grown by 1.10% in the last year.
Measured over the past years, TRS shows a small growth in Revenue. The Revenue has been growing by 4.85% on average per year.
EPS 1Y (TTM)-17.92%
EPS 3Y3.27%
EPS 5Y-0.11%
EPS growth Q2Q-40.32%
Revenue 1Y (TTM)1.1%
Revenue growth 3Y5.09%
Revenue growth 5Y4.85%
Revenue growth Q2Q3.08%

3.2 Future

The Earnings Per Share is expected to grow by 13.00% on average over the next years. This is quite good.
TRS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.13% yearly.
EPS Next Y16.06%
EPS Next 2Y13%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.15%
Revenue Next 2Y3.13%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

4

4. Valuation

4.1 Price/Earnings Ratio

TRS is valuated correctly with a Price/Earnings ratio of 15.04.
The rest of the industry has a similar Price/Earnings ratio as TRS.
Compared to an average S&P500 Price/Earnings ratio of 24.55, TRS is valued a bit cheaper.
The Price/Forward Earnings ratio is 12.96, which indicates a correct valuation of TRS.
Based on the Price/Forward Earnings ratio, TRS is valued a bit cheaper than the industry average as 60.87% of the companies are valued more expensively.
TRS is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 20.92, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 15.04
Fwd PE 12.96

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, TRS is valued a bit more expensive than 73.91% of the companies in the same industry.
78.26% of the companies in the same industry are cheaper than TRS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 31.45
EV/EBITDA 11.11

4.3 Compensation for Growth

TRS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
TRS's earnings are expected to grow with 13.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.94
PEG (5Y)N/A
EPS Next 2Y13%
EPS Next 3YN/A

2

5. Dividend

5.1 Amount

With a yearly dividend of 0.62%, TRS is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.89, TRS is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.39, TRS's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.62%

5.2 History

TRS has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years2

5.3 Sustainability

16.61% of the earnings are spent on dividend by TRS. This is a low number and sustainable payout ratio.
DP16.61%
EPS Next 2Y13%
EPS Next 3YN/A

TRIMAS CORP

NASDAQ:TRS (5/2/2024, 9:36:26 AM)

26.17

+0.38 (+1.47%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryContainers & Packaging
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.07B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 0.62%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 15.04
Fwd PE 12.96
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.94
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.01%
ROE 5.91%
ROCE
ROIC
ROICexc
ROICexgc
OM 7.81%
PM (TTM) 4.51%
GM 22.76%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.49
Quick Ratio 1.29
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-17.92%
EPS 3Y3.27%
EPS 5Y
EPS growth Q2Q
EPS Next Y16.06%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)1.1%
Revenue growth 3Y5.09%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y